β-catenin inhibitors belong to a distinctive chemical class known for their targeted interaction with the β-catenin protein, a vital component of the Wnt signaling pathway. This intricate pathway plays a pivotal role in various cellular processes, including embryonic development, tissue homeostasis, and cell proliferation. β-catenin, a key molecular player in this signaling cascade, is intricately involved in regulating gene transcription and cellular adhesion. β-catenin inhibitors act by selectively modulating the function of this protein, impeding its usual translocation into the nucleus. Within the nucleus, β-catenin usually collaborates with transcription factors to initiate the expression of specific genes, often associated with cell growth and survival. By hampering this translocation, β-catenin inhibitors exert a profound influence on downstream gene expression patterns, which can influence cellular behavior and contribute to various physiological and pathological conditions.
The structural diversity within the class of β-catenin inhibitors enables a range of interactions with the β-catenin protein, disrupting its protein-protein interactions and stability. These compounds often exhibit high selectivity, primarily targeting the β-catenin pathway while leaving other signaling cascades relatively unaffected. This selectivity is a key attribute, as it helps to avoid widespread off-target effects. The distinct chemical scaffold of β-catenin inhibitors underscores their significance as valuable tools for investigating cellular processes and holds promise for future research endeavors aimed at uncovering novel insights into the regulation of fundamental biological pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PRI-724 | 1422253-38-0 | sc-507535 | 25 mg | $260.00 | ||
Another inhibitor targeting β-catenin's interaction with CBP. It was designed to hinder the transcriptional activity of β-catenin in cancer cells. | ||||||
β-Catenin/Tcf Inhibitor, FH535 | 108409-83-2 | sc-221398 sc-221398A | 10 mg 50 mg | $182.00 $374.00 | 7 | |
FH535 interferes with both Wnt and peroxisome proliferator-activated receptor (PPAR) signaling pathways. It has been shown to inhibit β-catenin/TCF transcriptional activity. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
XAV939 promotes the degradation of β-catenin by enhancing the activity of axin, a protein involved in the degradation complex that targets β-catenin for destruction. | ||||||
1-[1,1′-Biphenyl]-4-yl-2-(2,3-dihydro-9H-imidazo[1,2-a]benzimidazol-9-yl)-ethanone Hydrobromide | 1219184-91-4 | sc-503576 | 10 mg | $360.00 | ||
This compound inhibits the interaction between β-catenin and TCF transcription factors, thereby blocking the transcriptional activation of β-catenin. | ||||||
G007-LK | 1380672-07-0 | sc-507467 | 1 mg | $48.00 | ||
G007-LK disrupts the interaction between β-catenin and TBL1 (transducin beta-like protein 1), which is involved in the β-catenin degradation pathway. | ||||||
LGK 974 | 1243244-14-5 | sc-489380 sc-489380A | 5 mg 50 mg | $359.00 $1295.00 | 2 | |
LGK974 is a selective inhibitor of porcupine, an enzyme that is essential for Wnt ligand secretion. Inhibition of porcupine disrupts Wnt signaling, which includes β-catenin activation. | ||||||
PKF118-310 | 84-82-2 | sc-364590 sc-364590A | 5 mg 25 mg | $180.00 $651.00 | ||
PKF118-310 disrupts the binding between β-catenin and TCF, inhibiting the downstream signaling of the Wnt pathway. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $214.00 $326.00 $1275.00 | 1 | |
Wnt-C59 is a porcupine inhibitor that blocks Wnt ligand secretion, thereby inhibiting the activation of β-catenin. | ||||||